In Search Of Antivirals For The Next Pandemic, A New Fund To De-Risk R&D

First Target Is Worrying Nipah Virus Family

 
• By Andrew McConaghie

Novo Nordisk Foundation, the Gates Foundation and Open Philanthropy are providing an initial $90m to fund more antiviral candidates through to proof-of-concept Phase II studies.

Paxlovid
Pfizer's Paxlovid is now being rolled out two years into the pandemic - the world can be better prepared next time, but early antiviral drug discovery needs to be properly funded. • Source: Alamy

More from COVID-19

More from Scrip